跳至主要内容
临床试验/NCT02665455
NCT02665455已完成不适用

Evaluation of the Accuracy of the FreeStyle Libre Flash Glucose Monitoring System - Use in Pregnancy

Abbott Diabetes Care26 个研究点 分布在 2 个国家目标入组 83 人开始时间: 2016年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
83
试验地点
26
主要终点
Point Accuracy Determined as % Within Consensus Error Grid Zone A

研究概览

简要总结

To evaluate the point accuracy of the FreeStyle Libre Flash Glucose Monitoring System when used at home by pregnant women with diabetes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Type 1, type 2 or Gestational Diabetes Mellitus (GDM) (confirmed diagnosis via Oral Glucose Tolerance Test (OGTT))
  • Currently testing Blood Glucose(BG), on average at least 2 times per day
  • Participant is ≥12+0 weeks gestation with a singleton pregnancy
  • In the investigator's opinion, technically capable of using device

排除标准

  • Concomitant disease or condition that may compromise patient safety including and not limited to; cardiac disease or event, sickle cell disease, cystic fibrosis, severe mental illness, known or suspected eating disorder or any uncontrolled long term medical condition
  • Currently receiving dialysis treatment or planning to receive dialysis during the study or, moderate to advanced nephropathy (serum creatinine ≥120 micromol/litre or total protein excretion exceeds 2 g/day or urinary albumin:creatinine ratio >30 mg/mmol, estimated glomerular filtration rate (eGFR) may not be used)
  • Diabetic Ketoacidosis (DKA) (in the previous 6 months)
  • Known (or suspected) allergy to medical grade adhesives
  • In the investigator's opinion the participant is unsuitable to participate due to any other cause/reason, considering guidelines (e.g. National Institute for Health and Care Excellence (NICE) and International Diabetes Federation(IDF)) for Diabetes in Pregnancy for HbA1c and Blood Pressure
  • Experiencing any of the following conditions for current pregnancy:
  • Pre-eclampsia
  • HELLP syndrome (haemolysis, elevated liver enzymes and low platelet count)
  • Prescribed Tocolytic drugs for treatment of preterm labour

研究组 & 干预措施

Intervention

Experimental

FreeStyle Libre Flash Glucose Monitoring System

干预措施: FreeStyle Libre Flash Glucose Monitoring System (Device)

结局指标

主要结局

Point Accuracy Determined as % Within Consensus Error Grid Zone A

时间窗: 14 days

Point accuracy of Sensor based glucose values versus fingerstick blood glucose determined as % within Consensus Error Grid zone A. Zone A is defined as the zone of "clinical accurate measurements with no effect on clinical action."

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (26)

Loading locations...

相似试验